• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒病(COVID-19)出院患者长期症状及预后的危险因素:一项前瞻性、多中心观察性研究

Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.

作者信息

Legrand Matthieu, Fong Nicholas, Laouénan Cédric, Ghosn Jade, Thill Benoit, Faure Karine, Garot Denis, Goujard Cécile, Curlier Elodie, Resche-Rigon Matthieu, Rossignol Patrick, Pirracchio Romain

机构信息

Department of Anesthesia and Perioperative Care, UCSF, San Francisco, CA, USA.

School of Medicine, University of California, San Francisco, California, USA.

出版信息

BMJ Med. 2022 Jun 17;1(1):e000093. doi: 10.1136/bmjmed-2021-000093. eCollection 2022.

DOI:10.1136/bmjmed-2021-000093
PMID:36936553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9951375/
Abstract

OBJECTIVE

To investigate risk factors and subphenotypes associated with long term symptoms and outcomes after hospital admission for covid-19.

DESIGN

Prospective, multicentre observational study.

SETTING

93 hospitals in France.

PARTICIPANTS

Data from 2187 adults admitted to hospital with covid-19 in France between 1 February 2020 and 30 June 2021.

MAIN OUTCOME MEASURES

Primary endpoint was the total number of persistent symptoms at six months after hospital admission that were not present before admission. Outcomes examined at six months were persistent symptoms, Hospital Anxiety and Depression Scale, six minute walk test distances, 36-Item Short Form Health Survey scores, and ability to resume previous professional activities and self-care. Secondary endpoints included vital status at six months, and results of standardised quality-of-life scores. Additionally, an unsupervised consensus clustering algorithm was used to identify subphenotypes based on the severity of hospital course received by patients.

RESULTS

1109 (50.7%) of 2187 participants had at least one persistent symptom. Factors associated with an increased number of persistent symptoms were in-hospital supplemental oxygen (odds ratio 1.12, 95% confidence interval 1 to 1.24), no intensive care unit admission (1.15, 1.01 to 1.32), female sex (1.33, 1.22 to 1.45), gastrointestinal haemorrhage (1.51, 1.02 to 2.23), a thromboembolic event (1.66, 1.17 to 2.34), and congestive heart failure (1.76, 1.27 to 2.43). Three subphenotypes were identified: including patients with the least severe hospital course (based on ventilatory support requirements). Although Hospital Anxiety and Depression Scale scores were within normal values for all groups, patients of intermediate severity and more comorbidities had a higher median Hospital Anxiety and Depression Scale score than did the other subphenotypes. Patients in the subphenotype with most severe hospital course had worse short form-36 scores and were less able to resume their professional activity or care for themselves as before compared with other subphenotypes.

CONCLUSIONS

Persistent symptoms after hospital admission were frequent, regardless of acute covid-19 severity. However, patients in more severe subphenotypes had a significantly worse functional status and were less likely to resume their professional activity or able to take care of themselves as before.

TRIAL REGISTRATION

NCT04262921.

摘要

目的

调查新型冠状病毒肺炎(COVID-19)住院后长期症状及预后的危险因素和亚表型。

设计

前瞻性、多中心观察性研究。

地点

法国的93家医院。

参与者

2020年2月1日至2021年6月30日期间在法国因COVID-19住院的2187名成年人的数据。

主要结局指标

主要终点为住院6个月后出现的、入院前不存在的持续症状总数。6个月时检查的结局包括持续症状、医院焦虑抑郁量表、6分钟步行试验距离、简明健康状况调查36项评分,以及恢复先前职业活动和自我护理的能力。次要终点包括6个月时的生命状态和标准化生活质量评分结果。此外,使用无监督一致性聚类算法根据患者接受的住院病程严重程度识别亚表型。

结果

2187名参与者中有1109名(50.7%)至少有一种持续症状。与持续症状数量增加相关的因素包括住院期间补充氧气(比值比1.12,95%置信区间1至1.24)、未入住重症监护病房(1.15,1.01至1.32)、女性(1.33,1.22至1.45)、胃肠道出血(1.51,1.02至2.23)、血栓栓塞事件(1.66,1.17至2.34)和充血性心力衰竭(1.76,1.27至2.43)。识别出三种亚表型:包括住院病程最轻的患者(基于通气支持需求)。尽管所有组的医院焦虑抑郁量表评分均在正常范围内,但中度严重程度且合并症较多的患者的医院焦虑抑郁量表中位数评分高于其他亚表型。与其他亚表型相比,住院病程最严重的亚表型患者的简明健康状况调查36项评分更差,恢复职业活动或像以前一样自我护理的能力更低。

结论

无论急性COVID-19的严重程度如何,住院后持续症状都很常见。然而,更严重亚表型的患者功能状态明显更差,恢复职业活动或像以前一样自我护理的可能性更小。

试验注册

NCT04262921。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/4acac23f6567/bmjmed-2021-000093f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/693f233fb55e/bmjmed-2021-000093f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/112c41772145/bmjmed-2021-000093f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/c2249ac898f0/bmjmed-2021-000093f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/365fe08ea320/bmjmed-2021-000093f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/4acac23f6567/bmjmed-2021-000093f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/693f233fb55e/bmjmed-2021-000093f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/112c41772145/bmjmed-2021-000093f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/c2249ac898f0/bmjmed-2021-000093f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/365fe08ea320/bmjmed-2021-000093f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/9951375/4acac23f6567/bmjmed-2021-000093f05.jpg

相似文献

1
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.新冠病毒病(COVID-19)出院患者长期症状及预后的危险因素:一项前瞻性、多中心观察性研究
BMJ Med. 2022 Jun 17;1(1):e000093. doi: 10.1136/bmjmed-2021-000093. eCollection 2022.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.COVID-19 相关急性呼吸窘迫综合征患者的纵向呼吸亚表型:来自三个观察队列的结果。
Lancet Respir Med. 2021 Dec;9(12):1377-1386. doi: 10.1016/S2213-2600(21)00365-9. Epub 2021 Oct 13.
5
A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".一项评估使用 gammaCore®-Sapphire 设备进行迷走神经刺激治疗中度至重度 CoViD-19 呼吸症状的前瞻性、随机、对照研究(SAVIOR):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 26;21(1):576. doi: 10.1186/s13063-020-04486-w.
6
COVID-19 subphenotypes at hospital admission are associated with mortality: a cross-sectional study.COVID-19 住院时的亚型与死亡率相关:一项横断面研究。
Ann Med. 2023 Dec;55(1):12-23. doi: 10.1080/07853890.2022.2148733.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
9
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
10
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 2 年后的健康结局:一项纵向队列研究。
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.

引用本文的文献

1
Long-term multidimensional patient-centred outcomes after hospitalisation for COVID-19: do not only focus on disease severity.新型冠状病毒肺炎(COVID-19)住院后的长期多维度以患者为中心的结局:不要只关注疾病严重程度。
BMJ Open Respir Res. 2025 Jun 8;12(1):e002789. doi: 10.1136/bmjresp-2024-002789.
2
Socio-demographic and clinical predictors of post-acute, mid-and long-term psychological sequelae of COVID-19: a two-year cross-sectional investigation on 1317 patients at the University Hospital of Verona.新冠病毒病急性后期、中期和长期心理后遗症的社会人口学及临床预测因素:对维罗纳大学医院1317例患者的两年横断面调查
Arch Public Health. 2024 Oct 31;82(1):198. doi: 10.1186/s13690-024-01426-x.
3

本文引用的文献

1
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.需要进行全球监测、研究与合作,以增进对新冠长期症状的了解并改善其管理。
Lancet. 2021 Dec 4;398(10316):2057-2059. doi: 10.1016/S0140-6736(21)02444-2. Epub 2021 Nov 10.
2
Female gender is associated with long COVID syndrome: a prospective cohort study.女性性别与长新冠综合征相关:一项前瞻性队列研究。
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16. doi: 10.1016/j.cmi.2021.11.002. Epub 2021 Nov 9.
3
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
Lower Urinary Tract Symptoms in a prospective cohort of COVID-19 survivors.
前瞻性队列研究中 COVID-19 幸存者的下尿路症状。
Int Braz J Urol. 2024 May-Jun;50(3):287-295. doi: 10.1590/S1677-5538.IBJU.2023.0546.
4
One-Year Survival and Hospital-free Days in Critical Illness After Viral Pneumonia.病毒性肺炎后危重症患者的一年生存率及无住院天数
Am J Respir Crit Care Med. 2024 Apr 15;209(8):1019-1022. doi: 10.1164/rccm.202310-1771LE.
5
Female sex and burden of depressive symptoms predict insufficient response to telemedical treatment in adult attention-deficit/hyperactivity disorder: results from a naturalistic patient cohort during the COVID-19 pandemic.女性性别和抑郁症状负担预示着成人注意力缺陷多动障碍患者对远程医疗治疗反应不足:COVID-19大流行期间一项自然主义患者队列研究的结果
Front Psychiatry. 2023 Oct 5;14:1193898. doi: 10.3389/fpsyt.2023.1193898. eCollection 2023.
6
PIM-COVID study: protocol for a multicentre, longitudinal study measuring the psychological impact of surviving an intensive care admission due to COVID-19 on patients in the UK.PIM-COVID 研究:一项多中心、纵向研究的方案,旨在测量因 COVID-19 而在英国接受重症监护的患者在幸存后的心理影响。
BMJ Open. 2023 Sep 27;13(9):e071730. doi: 10.1136/bmjopen-2023-071730.
7
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎后新发糖尿病的患病率和风险:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Sep 4;14:1215879. doi: 10.3389/fendo.2023.1215879. eCollection 2023.
8
Long covid: risk factors, outcomes, and future directions for research.长期新冠:风险因素、结局及未来研究方向
BMJ Med. 2022 Jun 17;1(1):e000257. doi: 10.1136/bmjmed-2022-000257. eCollection 2022.
在 COVID-19 大流行期间,法国成年人中自我报告的 COVID-19 感染和 SARS-CoV-2 血清学检测结果与持续的身体症状之间的关联。
JAMA Intern Med. 2022 Jan 1;182(1):19-25. doi: 10.1001/jamainternmed.2021.6454.
4
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.COVID-19 后住院患者的身体、认知和心理健康影响(PHOSP-COVID):一项英国多中心前瞻性队列研究。
Lancet Respir Med. 2021 Nov;9(11):1275-1287. doi: 10.1016/S2213-2600(21)00383-0. Epub 2021 Oct 7.
5
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 1 年结局:一项纵向队列研究。
Lancet. 2021 Aug 28;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.
6
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.新型冠状病毒肺炎的长期后遗症:针对既往存在和新发气道疾病患者的研究重点国际共识
Lancet Respir Med. 2021 Dec;9(12):1467-1478. doi: 10.1016/S2213-2600(21)00286-1. Epub 2021 Aug 17.
7
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol.新型冠状病毒肺炎后从英国医院出院的成年人的长期新冠症状:一项采用国际严重急性呼吸道感染和新发传染病临床协作组(ISARIC)世界卫生组织临床特征协议的前瞻性多中心队列研究。
Lancet Reg Health Eur. 2021 Sep;8:100186. doi: 10.1016/j.lanepe.2021.100186. Epub 2021 Aug 6.
8
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19.住院治疗的严重 COVID-19 患者的六个月预后情况。
J Gen Intern Med. 2021 Dec;36(12):3772-3777. doi: 10.1007/s11606-021-07032-9. Epub 2021 Aug 5.
9
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.COVID-19 住院后成年人持续症状的发生率和危险因素。
Clin Exp Allergy. 2021 Sep;51(9):1107-1120. doi: 10.1111/cea.13997. Epub 2021 Aug 12.
10
Long covid-mechanisms, risk factors, and management.长新冠的发病机制、危险因素和管理。
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.